World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

World Top Biopharmaceutical Companies 2024
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.

  1. Sino Biopharmaceutical

    World Rank (Jan-05-2024)
    2,021
    Market Cap (Jan-05-2024)
    7.944 Billion USD
    World Rank (Jul-30-2023)
    1,899
    Market Cap (Jul-30-2023)
    8.629 Billion USD
    World Rank (Dec-25-2022)
    1,459
    Market Cap (Dec-25-2022)
    10.655 Billion USD
    World Rank (Jan-07-2022)
    1,423
    Market Cap (Jan-07-2022)
    14.15 Billion USD
    Annual Revenue in USD
    4,026 Million USD
    Annual Operating Income in USD
    844 Million USD
    Annual Net Income in USD
    356 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Hong Kong
    Yahoo @ HongKong
    Company Profile
    SINO BIOPHARMACEUTICAL is BioPharmaceutical company with headquarters is in Hong Kong. The products include a variety of biological drugs and chemical drugs, and are in an advantageous position in many potential therapeutic fields such as liver disease, tumor, cardiovascular and cerebrovascular disease, orthopedics, digestive system, anti-infection and respiratory diseases.
    Company Website
    SINO BIOPHARM - Bio-Pharmaceutical Company
    Wikipedia
    Wikipedia

  2. Innovent Biologics

    World Rank (Jan-05-2024)
    2,038
    Market Cap (Jan-05-2024)
    7.866 Billion USD
    World Rank (Jul-30-2023)
    2,192
    Market Cap (Jul-30-2023)
    7.200 Billion USD
    World Rank (Dec-25-2022)
    2,283
    Market Cap (Dec-25-2022)
    6.149 Billion USD
    World Rank (Jan-07-2022)
    2,372
    Market Cap (Jan-07-2022)
    7.52 Billion USD
    Annual Revenue in USD
    639 Million USD
    Annual Operating Income in USD
    -362 Million USD
    Annual Net Income in USD
    -305 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    China
    Yahoo @ HongKong
    Company Profile
    Innovent Biologics is the leading biopharmaceutical company with research platform focusing on new drug discovery. The headquarters is in China.
    Company Website
    INNOVENT BIOLOGICS

  3. Cerevel Therapeutics Holdings Inc.

    World Rank (Jan-05-2024)
    2,079
    Market Cap (Jan-05-2024)
    7.635 Billion USD
    World Rank (Jul-30-2023)
    3,086
    Market Cap (Jul-30-2023)
    4.779 Billion USD
    World Rank (Dec-25-2022)
    2,820
    Market Cap (Dec-25-2022)
    4.805 Billion USD
    World Rank (Jan-07-2022)
    3,528
    Market Cap (Jan-07-2022)
    4.56 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -367 Million USD
    Annual Net Income in USD
    -351 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile

    Cerevel Therapeutics Holdings is a clinical stage biopharmaceutical company that combines a deep understanding of the biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) receptor pharmacology to discover and develop new therapies. The headquarters is in USA.

    Company Website
    CEREVEL THERAPEUTICS HOLDINGS, INC.

  4. Ascendis Pharma A/S

    World Rank (Jan-05-2024)
    2,135
    Market Cap (Jan-05-2024)
    7.414 Billion USD
    World Rank (Jul-30-2023)
    2,847
    Market Cap (Jul-30-2023)
    5.234 Billion USD
    World Rank (Dec-25-2022)
    2,096
    Market Cap (Dec-25-2022)
    6.791 Billion USD
    World Rank (Jan-07-2022)
    2,604
    Market Cap (Jan-07-2022)
    6.65 Billion USD
    Annual Revenue in USD
    56 Million USD
    Annual Operating Income in USD
    -619 Million USD
    Annual Net Income in USD
    -643 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Denmark
    Yahoo @ Nasdaq
    Company Profile
    Bio-pharmaceutical company with headquarters is in Denmark.
    Company Website
    ASCENDIS PHARMA A/S

  5. Apellis Pharmaceuticals

    World Rank (Jan-05-2024)
    2,186
    Market Cap (Jan-05-2024)
    7.197 Billion USD
    World Rank (Jul-30-2023)
    3,727
    Market Cap (Jul-30-2023)
    3.729 Billion USD
    World Rank (Dec-25-2022)
    2,468
    Market Cap (Dec-25-2022)
    5.624 Billion USD
    World Rank (Jan-07-2022)
    3,682
    Market Cap (Jan-07-2022)
    4.29 Billion USD
    Annual Revenue in USD
    75 Million USD
    Annual Net Income in USD
    -652 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Apellis Pharmaceuticals is a Biopharmaceutical company that is committed to leveraging courageous science, creativity and compassion to deliver life changing therapies. The company develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade including those within hematology, ophthalmology, nephrology and neurology. The headquarters is in USA.

    Company Website
    APELLIS PHARMACEUTICALS INC

  6. Intra-Cellular Therapies

    World Rank (Jan-05-2024)
    2,318
    Market Cap (Jan-05-2024)
    6.689 Billion USD
    World Rank (Jul-30-2023)
    2,600
    Market Cap (Jul-30-2023)
    5.833 Billion USD
    World Rank (Dec-25-2022)
    2,828
    Market Cap (Dec-25-2022)
    4.796 Billion USD
    World Rank (Jan-07-2022)
    4,331
    Market Cap (Jan-07-2022)
    3.51 Billion USD
    Annual Revenue in USD
    249 Million USD
    Annual Operating Income in USD
    -263 Million USD
    Annual Net Income in USD
    -256 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Intra-Cellular Therapies is a Biopharmaceutical company. It develops innovative treatments to improve the lives of individuals suffering from neuropsychiatric and neurologic disorders in order to reduce the burden on patients and their caregivers. The headquarters is in USA.

    Company Website
    INTRA-CELLULAR THERAPIES

  7. Reata Pharmaceuticals

    World Rank (Jan-05-2024)
    2,443
    World Rank (Jul-30-2023)
    2,443
    Market Cap (Jul-30-2023)
    6.278 Billion USD
    World Rank (Dec-25-2022)
    7,125
    Market Cap (Dec-25-2022)
    1.319 Billion USD
    World Rank (Jan-07-2022)
    9,134
    Market Cap (Jan-07-2022)
    1.05 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -278 Million USD
    Annual Net Income in USD
    -311 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Reata Pharmaceuticals is a Bio-pharmaceutical company with headquarters is in Texas, USA.

    Biogen acquired Reata Pharmaceuticals for 7.3 Billion USD in 2023.

    Company Website
    REATA PHARMACEUTICALS INC
    Wikipedia
    Wikipedia

  8. SK Biopharmaceuticals

    World Rank (Jan-05-2024)
    2,458
    Market Cap (Jan-05-2024)
    6.236 Billion USD
    World Rank (Jul-30-2023)
    2,963
    Market Cap (Jul-30-2023)
    5.022 Billion USD
    World Rank (Dec-25-2022)
    3,068
    Market Cap (Dec-25-2022)
    4.349 Billion USD
    World Rank (Jan-07-2022)
    2,773
    Market Cap (Jan-07-2022)
    6.17 Billion USD
    Annual Revenue in USD
    189 Million USD
    Annual Operating Income in USD
    -101 Million USD
    Annual Net Income in USD
    -107 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    South Korea
    Yahoo @ SouthKorea
    Company Profile

    SK Biopharmaceuticals is a Biopharmaceutical company that develops new drugs in support of innovations in the medical field. The headquarters is in South Korea.

    Company Website
    SK BIOPHARMACEUTICALS

  9. Vaxcyte Inc.

    World Rank (Jan-05-2024)
    2,495
    Market Cap (Jan-05-2024)
    6.122 Billion USD
    World Rank (Jul-30-2023)
    3,324
    Market Cap (Jul-30-2023)
    4.376 Billion USD
    World Rank (Dec-25-2022)
    3,506
    Market Cap (Dec-25-2022)
    3.686 Billion USD
    World Rank (Jan-07-2022)
    8,241
    Market Cap (Jan-07-2022)
    1.26 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -207 Million USD
    Annual Net Income in USD
    -223 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Vaxcyte is a Biotechnology company developing potentially superior and novel vaccines designed to prevent or treat the most common and deadly infectious diseases worldwide. It is having 43 employees as on 2019. The headquarters is in USA.

    Company Website
    VAXCYTE, INC.

  10. Eidos Therapeutics

    World Rank (Jan-05-2024)
    2,624
    World Rank (Jul-30-2023)
    2,624
    World Rank (Dec-25-2022)
    2,624
    World Rank (Jan-07-2022)
    2,624
    Headquarters Country
    USA
    Company Profile

    Eidos Therapeutics is a Biopharmaceutical company with headquarters is in California, USA.

    Eidos Therapeutics was acquired by BridgeBio Pharma Inc in 2021.

     

    Company Website
    EIDOS THERAPEUTICS INC

Share